vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and PATRIOT NATIONAL BANCORP INC (PNBK). Click either name above to swap in a different company.
PATRIOT NATIONAL BANCORP INC is the larger business by last-quarter revenue ($9.5M vs $9.2M, roughly 1.0× Foghorn Therapeutics Inc.). On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 44.3%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 11.5%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
FHTX vs PNBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $9.5M |
| Net Profit | $-21.7M | — |
| Gross Margin | — | — |
| Operating Margin | -258.2% | -36.3% |
| Net Margin | -234.3% | — |
| Revenue YoY | 223.8% | 44.3% |
| Net Profit YoY | -11.1% | — |
| EPS (diluted) | $-0.35 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $9.5M | ||
| Q3 25 | $8.2M | $7.2M | ||
| Q2 25 | $7.6M | $6.2M | ||
| Q1 25 | $6.0M | $6.7M | ||
| Q4 24 | $2.9M | $6.6M | ||
| Q3 24 | $7.8M | $7.1M | ||
| Q2 24 | $6.9M | $7.1M | ||
| Q1 24 | $5.0M | $7.7M |
| Q4 25 | $-21.7M | — | ||
| Q3 25 | $-15.8M | $-2.7M | ||
| Q2 25 | $-17.9M | $-5.0M | ||
| Q1 25 | $-18.8M | $-2.8M | ||
| Q4 24 | $-19.5M | — | ||
| Q3 24 | $-19.1M | $-27.0M | ||
| Q2 24 | $-23.0M | $-3.1M | ||
| Q1 24 | $-25.0M | $-299.0K |
| Q4 25 | -258.2% | -36.3% | ||
| Q3 25 | -226.9% | -36.9% | ||
| Q2 25 | -279.2% | -81.2% | ||
| Q1 25 | -385.0% | -41.5% | ||
| Q4 24 | -840.5% | -205.4% | ||
| Q3 24 | -305.5% | -32.4% | ||
| Q2 24 | -386.6% | -56.5% | ||
| Q1 24 | -558.3% | -3.0% |
| Q4 25 | -234.3% | — | ||
| Q3 25 | -194.4% | -36.8% | ||
| Q2 25 | -237.3% | -80.4% | ||
| Q1 25 | -316.4% | -41.6% | ||
| Q4 24 | -682.9% | — | ||
| Q3 24 | -244.9% | -378.9% | ||
| Q2 24 | -333.6% | -43.5% | ||
| Q1 24 | -495.4% | -3.9% |
| Q4 25 | $-0.35 | $0.13 | ||
| Q3 25 | $-0.25 | $-0.03 | ||
| Q2 25 | $-0.28 | $-0.06 | ||
| Q1 25 | $-0.30 | $-0.21 | ||
| Q4 24 | $-0.23 | $-2.40 | ||
| Q3 24 | $-0.31 | $-6.78 | ||
| Q2 24 | $-0.45 | $-0.77 | ||
| Q1 24 | $-0.59 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | — |
| Total DebtLower is stronger | — | $16.4M |
| Stockholders' EquityBook value | $-108.5M | $94.7M |
| Total Assets | $198.1M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | — | ||
| Q3 25 | $89.3M | — | ||
| Q2 25 | $72.6M | — | ||
| Q1 25 | $61.0M | — | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $57.7M | — | ||
| Q2 24 | $138.9M | — | ||
| Q1 24 | $79.3M | — |
| Q4 25 | — | $16.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $33.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-108.5M | $94.7M | ||
| Q3 25 | $-89.7M | $95.0M | ||
| Q2 25 | $-76.7M | $66.2M | ||
| Q1 25 | $-61.7M | $57.1M | ||
| Q4 24 | $-45.5M | $4.3M | ||
| Q3 24 | $-28.3M | $16.4M | ||
| Q2 24 | $-14.3M | $40.5M | ||
| Q1 24 | $-97.5M | $43.6M |
| Q4 25 | $198.1M | $1.1B | ||
| Q3 25 | $205.0M | $950.8M | ||
| Q2 25 | $226.2M | $930.0M | ||
| Q1 25 | $258.7M | $956.6M | ||
| Q4 24 | $284.0M | $1.0B | ||
| Q3 24 | $308.4M | $974.1M | ||
| Q2 24 | $328.6M | $1.0B | ||
| Q1 24 | $255.0M | $1.1B |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 7.76× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $-14.2M |
| Free Cash FlowOCF − Capex | — | $-14.3M |
| FCF MarginFCF / Revenue | — | -150.8% |
| Capex IntensityCapex / Revenue | 0.0% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-24.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $-14.2M | ||
| Q3 25 | $-18.9M | $-5.2M | ||
| Q2 25 | $-21.0M | $921.0K | ||
| Q1 25 | $-24.0M | $-5.8M | ||
| Q4 24 | $-24.5M | $2.7M | ||
| Q3 24 | $-21.0M | $-2.6M | ||
| Q2 24 | $-25.5M | $6.0M | ||
| Q1 24 | $-29.3M | $1.8M |
| Q4 25 | — | $-14.3M | ||
| Q3 25 | — | $-5.3M | ||
| Q2 25 | $-21.0M | $918.0K | ||
| Q1 25 | $-24.0M | $-5.9M | ||
| Q4 24 | $-25.0M | $2.6M | ||
| Q3 24 | $-21.3M | $-2.7M | ||
| Q2 24 | $-25.6M | $6.0M | ||
| Q1 24 | $-29.4M | $1.8M |
| Q4 25 | — | -150.8% | ||
| Q3 25 | — | -72.8% | ||
| Q2 25 | -278.2% | 14.8% | ||
| Q1 25 | -403.2% | -88.0% | ||
| Q4 24 | -875.3% | 39.9% | ||
| Q3 24 | -273.0% | -37.3% | ||
| Q2 24 | -371.0% | 84.6% | ||
| Q1 24 | -583.1% | 23.0% |
| Q4 25 | 0.0% | 1.8% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.5% | 1.0% | ||
| Q4 24 | 16.8% | 0.8% | ||
| Q3 24 | 4.0% | 0.9% | ||
| Q2 24 | 0.2% | 0.7% | ||
| Q1 24 | 2.0% | 0.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
